Cancer stem cells. VEGF promotes stemness.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer.Biomedicines · 2023
   Article
2. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.The Biochemical journal · 2018
   Review
3. Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma.Molecular neurobiology · 2017
   Article
4. The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment.Stem cells international · 2017
   Review
5. Gli1 mediates lung cancer cell proliferation and Sonic Hedgehog-dependent mesenchymal cell activation.PloS one · 2013
   Article
6. Cancer stem cells, tumor dormancy, and metastasis.Frontiers in endocrinology · 2012
   Article

Corrections and comments

• Comment on
  A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.